• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估药物-脂质相互作用以及在新制备的和由喷雾干燥粉末重构的固体脂质微粒(SLM)液体分散体中活性物质分布的分析技术。

Analytical Techniques for the Assessment of Drug-Lipid Interactions and the Active Substance Distribution in Liquid Dispersions of Solid Lipid Microparticles (SLM) Produced de novo and Reconstituted from Spray-Dried Powders.

作者信息

Wolska Eliza, Sznitowska Małgorzata, Krzemińska Katarzyna, Ferreira Monteiro Maria

机构信息

Department of Pharmaceutical Technology, Medical University of Gdansk, Hallera 107, 80-416 Gdansk, Poland.

The Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.

出版信息

Pharmaceutics. 2020 Jul 15;12(7):664. doi: 10.3390/pharmaceutics12070664.

DOI:10.3390/pharmaceutics12070664
PMID:32679745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407395/
Abstract

Solid lipid microparticles (SLM) can be presented as liquid suspension or spray-dried powder. The main challenge in SLM technology is to precisely determine the location of the active substance (API) in the different compartments of the formulation and its changes during SLM processing. Therefore, the purpose of the research was to assess the distribution of the API and to investigate the nature of the API-lipid interaction when the formulation was subjected to spray drying, with an indication of the most suitable techniques for this purpose. SLM were prepared with two various lipids (Compritol or stearic acid) and two model APIs: cyclosporine (0.1% and 1% ) and spironolactone (0.1% and 0.5% ). Physicochemical characterizations of the formulations, before and after spray drying, were performed by differential scanning calorimetry (DSC), atomic force microscopy (AFM), Raman spectroscopy and nuclear magnetic resonance (NMR). The API distribution between the SLM matrix, SLM surface and the aqueous phase was determined, and the release study was performed. It was demonstrated that, in general, the spray drying did not affect the drug release and drug distribution; however, some changes were observed in the SLM with Compritol and when the API concentration was lower. Only in the SLM with stearic acid was a change in the DSC curves noted. Measurements with the AFM technique proved to be a useful method for detecting differences in the surface properties between the placebo and API-loaded SLM, while the Raman spectroscopy did not show such evident differences.

摘要

固体脂质微粒(SLM)可以制成液体悬浮液或喷雾干燥粉末。SLM技术的主要挑战在于精确确定活性物质(原料药,API)在制剂不同组分中的位置及其在SLM加工过程中的变化。因此,本研究的目的是评估原料药的分布,并研究制剂进行喷雾干燥时原料药与脂质相互作用的性质,同时指出最适合此目的的技术。使用两种不同的脂质(Compritol或硬脂酸)和两种模型原料药制备了SLM:环孢素(0.1%和1%)和螺内酯(0.1%和0.5%)。通过差示扫描量热法(DSC)、原子力显微镜(AFM)、拉曼光谱和核磁共振(NMR)对喷雾干燥前后的制剂进行了物理化学表征。测定了SLM基质、SLM表面和水相之间的原料药分布,并进行了释放研究。结果表明,一般来说,喷雾干燥不影响药物释放和药物分布;然而,在含有Compritol的SLM中以及原料药浓度较低时观察到了一些变化。仅在含有硬脂酸的SLM中,DSC曲线出现了变化。AFM技术测量被证明是检测安慰剂和载有原料药的SLM表面性质差异的有用方法,而拉曼光谱未显示出如此明显的差异。

相似文献

1
Analytical Techniques for the Assessment of Drug-Lipid Interactions and the Active Substance Distribution in Liquid Dispersions of Solid Lipid Microparticles (SLM) Produced de novo and Reconstituted from Spray-Dried Powders.用于评估药物-脂质相互作用以及在新制备的和由喷雾干燥粉末重构的固体脂质微粒(SLM)液体分散体中活性物质分布的分析技术。
Pharmaceutics. 2020 Jul 15;12(7):664. doi: 10.3390/pharmaceutics12070664.
2
Distribution of Drug Substances in Solid Lipid Microparticles (SLM)-Methods of Analysis and Interpretation.药物在固体脂质微粒(SLM)中的分布——分析与解读方法
Pharmaceutics. 2022 Jan 31;14(2):335. doi: 10.3390/pharmaceutics14020335.
3
Determination of solid state characteristics of spray-congealed Ibuprofen solid lipid microparticles and their impact on sustaining drug release.喷雾冷凝法制备的布洛芬固体脂质微粒的固态特性测定及其对药物缓释的影响
Mol Pharm. 2015 May 4;12(5):1592-604. doi: 10.1021/acs.molpharmaceut.5b00015. Epub 2015 Apr 15.
4
Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).载有环孢素 A 的稳定、长效滴眼剂的技术,分布在脂质基质和固体脂质微球(SLM)的表面之间。
Int J Pharm. 2013 Jan 30;441(1-2):449-57. doi: 10.1016/j.ijpharm.2012.11.009. Epub 2012 Nov 16.
5
Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.用于透皮给药的睾酮固体脂质微粒。制剂及理化特性
J Microencapsul. 2007 Aug;24(5):457-75. doi: 10.1080/02652040701368865.
6
Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies.含有杜松子油作为抗痤疮局部用载体的固体脂质微粒(SLM):初步研究。
Pharm Dev Technol. 2005;10(4):479-87. doi: 10.1080/10837450500299727.
7
The impact of particle preparation methods and polymorphic stability of lipid excipients on protein distribution in microparticles.颗粒制备方法和脂质辅料的多晶型稳定性对微粒中蛋白质分布的影响。
Drug Dev Ind Pharm. 2017 Dec;43(12):2032-2042. doi: 10.1080/03639045.2017.1361967. Epub 2017 Aug 11.
8
Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model.固体脂质微球给药后兔眼组织中环孢素 A 的分布及眼刺激性。
Eur J Pharm Sci. 2018 Aug 30;121:95-105. doi: 10.1016/j.ejps.2018.05.015. Epub 2018 May 16.
9
Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.喷雾干燥布洛芬三元无定形固体分散体:关键配方和工艺参数研究。
Eur J Pharm Biopharm. 2017 Nov;120:43-51. doi: 10.1016/j.ejpb.2017.08.005. Epub 2017 Aug 16.
10
Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.冷冻透射电子显微镜和原子力显微镜观察三元固体分散体水分散体中无定形普罗布考纳米颗粒的时变演变。
Mol Pharm. 2019 May 6;16(5):2184-2198. doi: 10.1021/acs.molpharmaceut.9b00158. Epub 2019 Apr 9.

引用本文的文献

1
Formulation, Optimization, and Ex vivo Permeation Study of Ritonavir-loaded Solid Lipid Nanoparticles.载利托那韦固体脂质纳米粒的处方、优化及体外渗透研究
Curr Pharm Des. 2025 Feb 25. doi: 10.2174/0113816128329768241230071303.
2
Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.用于克服姜黄素制剂挑战的纳米载体系统研究进展:当前见解
Nanomaterials (Basel). 2024 Apr 12;14(8):672. doi: 10.3390/nano14080672.
3
Comparison of the In Vitro Drug Release Methods for the Selection of Test Conditions to Characterize Solid Lipid Microparticles.

本文引用的文献

1
Solid lipid nanoparticles self-assembled from spray dried microparticles.喷雾干燥微丸自组装形成固体脂质纳米粒。
Int J Pharm. 2019 Dec 15;572:118784. doi: 10.1016/j.ijpharm.2019.118784. Epub 2019 Oct 30.
2
Propolis loaded liposomes: evaluation of antimicrobial and antioxidant activities.蜂胶负载脂质体:抗菌和抗氧化活性评价。
J Liposome Res. 2020 Jun;30(2):107-116. doi: 10.1080/08982104.2019.1599012. Epub 2019 Jul 30.
3
Influence of spray drying on the stability of food-grade solid lipid nanoparticles.喷雾干燥对食品级固体脂质纳米粒稳定性的影响。
用于选择表征固体脂质微粒测试条件的体外药物释放方法的比较
Pharmaceutics. 2023 Feb 3;15(2):511. doi: 10.3390/pharmaceutics15020511.
4
Distribution of Drug Substances in Solid Lipid Microparticles (SLM)-Methods of Analysis and Interpretation.药物在固体脂质微粒(SLM)中的分布——分析与解读方法
Pharmaceutics. 2022 Jan 31;14(2):335. doi: 10.3390/pharmaceutics14020335.
5
Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active.用于包封模型疏水性活性成分的固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)的制剂设计、生产及特性研究
Food Hydrocoll Health. 2021;1:None. doi: 10.1016/j.fhfh.2021.100024.
Food Res Int. 2019 May;119:741-750. doi: 10.1016/j.foodres.2018.10.056. Epub 2018 Oct 22.
4
Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy.载乙胺丁醇固体脂质纳米粒干粉吸入剂用于结核病治疗。
AAPS PharmSciTech. 2019 Feb 22;20(3):120. doi: 10.1208/s12249-019-1334-y.
5
Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model.固体脂质微球给药后兔眼组织中环孢素 A 的分布及眼刺激性。
Eur J Pharm Sci. 2018 Aug 30;121:95-105. doi: 10.1016/j.ejps.2018.05.015. Epub 2018 May 16.
6
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.载卡马西平固体脂质纳米粒和纳米结构脂质载体的理化性质表征及体内外评价。
Colloids Surf B Biointerfaces. 2018 Jul 1;167:73-81. doi: 10.1016/j.colsurfb.2018.03.052. Epub 2018 Mar 31.
7
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.可吸入颗粒药物传递系统治疗肺癌:纳米粒子、微粒子、纳米复合材料和纳米聚集体。
J Control Release. 2018 Jan 10;269:374-392. doi: 10.1016/j.jconrel.2017.11.036. Epub 2017 Nov 24.
8
Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement.喷雾冷冻固脂微球作为一种新工具控制双膦酸盐从磷酸钙骨水泥中的释放。
Eur J Pharm Biopharm. 2018 Jan;122:6-16. doi: 10.1016/j.ejpb.2017.10.002. Epub 2017 Oct 3.
9
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.利用固体脂质纳米粒作为载体的药物和生物活性天然产物经口腔给药的最新进展。
J Food Drug Anal. 2017 Apr;25(2):219-234. doi: 10.1016/j.jfda.2017.02.001. Epub 2017 Mar 14.
10
The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN).脂质组合物和表面活性剂对固体脂质微球和纳米球(SLM和SLN)特性的影响。
Eur J Pharm Biopharm. 2017 Jan;110:24-30. doi: 10.1016/j.ejpb.2016.10.023. Epub 2016 Nov 1.